USD 25.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -1.27 Million USD | 93.05% |
2022 | - USD | -221.21% |
2021 | - USD | 22.5% |
2020 | - USD | 18.59% |
2019 | - USD | 220.45% |
2018 | - USD | -166.17% |
2017 | - USD | 275.48% |
2016 | - USD | 297.98% |
2015 | - USD | -143.39% |
2014 | - USD | -74.01% |
2013 | - USD | 51.95% |
2012 | - USD | 35233.33% |
2011 | -384.05 Thousand USD | 94.57% |
2010 | -7.06 Million USD | 55.44% |
2009 | -15.86 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q1 | -6.15 Million USD | -72.08% |
2023 Q2 | -6.15 Million USD | 0.0% |
2023 FY | - USD | 93.05% |
2023 Q4 | -2.23 Million USD | 0.0% |
2023 Q3 | -2.23 Million USD | 63.61% |
2022 Q4 | -3.57 Million USD | 0.0% |
2022 Q3 | -3.57 Million USD | -59.78% |
2022 Q1 | -2.23 Million USD | 44.55% |
2022 Q2 | -2.23 Million USD | 0.0% |
2022 FY | - USD | -221.21% |
2021 Q2 | -1.4 Million USD | 0.0% |
2021 Q4 | -4.03 Million USD | 0.0% |
2021 Q1 | -1.4 Million USD | -5.16% |
2021 Q3 | -4.03 Million USD | -186.44% |
2021 FY | - USD | 22.5% |
2020 FY | - USD | 18.59% |
2020 Q4 | -1.33 Million USD | 0.0% |
2020 Q2 | -1.71 Million USD | 0.0% |
2020 Q3 | -1.33 Million USD | 21.93% |
2020 Q1 | -1.71 Million USD | 0.84% |
2019 Q3 | -1.73 Million USD | 22.51% |
2019 FY | - USD | 220.45% |
2019 Q4 | -1.73 Million USD | 0.0% |
2019 Q2 | -2.23 Million USD | -0.0% |
2019 Q1 | -2.23 Million USD | -74.99% |
2018 Q1 | -1.03 Million USD | -114.42% |
2018 FY | - USD | -166.17% |
2018 Q2 | -1.03 Million USD | 0.0% |
2018 Q3 | -1.27 Million USD | -23.73% |
2018 Q4 | -1.27 Million USD | 0.0% |
2017 Q3 | -480.88 Thousand USD | 62.53% |
2017 Q4 | -480.88 Thousand USD | 0.0% |
2017 FY | - USD | 275.48% |
2017 Q1 | -1.28 Million USD | -280.38% |
2017 Q2 | -1.28 Million USD | -0.0% |
2016 Q4 | -337.36 Thousand USD | 0.0% |
2016 Q3 | -337.36 Thousand USD | 60.63% |
2016 Q1 | -856.92 Thousand USD | -213.73% |
2016 FY | - USD | 297.98% |
2016 Q2 | -856.92 Thousand USD | 0.0% |
2015 Q1 | -1.24 Million USD | -119.94% |
2015 FY | - USD | -143.39% |
2015 Q3 | -273.14 Thousand USD | 78.09% |
2015 Q4 | -273.14 Thousand USD | 0.0% |
2015 Q2 | -1.24 Million USD | 0.0% |
2014 FY | - USD | -74.01% |
2014 Q4 | 6.25 Million USD | 0.0% |
2014 Q3 | 6.25 Million USD | 194.0% |
2014 Q2 | -6.65 Million USD | -0.0% |
2014 Q1 | -6.65 Million USD | -1968.14% |
2013 Q4 | 355.99 Thousand USD | 0.0% |
2013 FY | - USD | 51.95% |
2013 Q3 | 355.99 Thousand USD | -73.19% |
2013 Q2 | 1.32 Million USD | -0.0% |
2013 Q1 | 1.32 Million USD | 1475.34% |
2012 FY | - USD | 35233.33% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | 84.28 Thousand USD | 0.0% |
2012 Q4 | 84.28 Thousand USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 94.57% |
2010 Q2 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | 55.44% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Ameriprise Financial, Inc. | 3.4 Billion USD | 100.037% |
Gladstone Investment Corporation | 63.52 Million USD | 102.002% |
Principal Financial Group, Inc. | 1.05 Billion USD | 100.121% |
Africa Opportunity Fund Limited | -1.29 Million USD | 1.671% |
BH Macro Limited | -42.01 Million USD | 96.974% |
BioPharma Credit PLC | - USD | Infinity% |
CATCo Reinsurance Opportunities Fund Ltd. | - USD | Infinity% |
Craven House Capital Plc | -5.45 Million USD | 76.669% |
JPEL Private Equity Limited | - USD | Infinity% |
Pershing Square Holdings, Ltd. | - USD | Infinity% |
Ecofin U.S. Renewables Infrastructure Trust PLC | -6.72 Million USD | 81.087% |
RTW Venture Fund Limited | - USD | Infinity% |
Tufton Oceanic Assets Limited | - USD | Infinity% |
Symphony International Holdings Limited | -101.89 Million USD | 98.752% |
Tetragon Financial Group Limited | - USD | Infinity% |
Taylor Maritime Investments Limited | -51.6 Million USD | 97.536% |
TMT Investments PLC | 6.07 Million USD | 120.942% |